-
Deals Roll at JPM26, Policy Front and Center, IPOs Are Back, FDA Stays Busy
14 Jan 2026 11:25 GMT
… -1/VEGF bispecific and Novartis struck a $1.5 billion … in time for JPM, the IPO window cracked open, with Aktis …
-
Aktis Has First Biotech IPO of 2026, Raising $318M to Expand the Reach of Radiopharmaceuticals
09 Jan 2026 17:47 GMT
… 2025 that saw limited biotech IPO activity, Aktis found sufficient … technology platform. In the IPO filing, Aktis says its … participation from Novartis and Bristol Myers Squibb. Before the IPO, Aktis … million. Combined with the IPO proceeds, Aktis said it …
-
Aktis raises $318M in 2026’s first biotech IPO
09 Jan 2026 04:58 GMT
… $318 million from an initial public offering, the first for a … targets.
Prior to its IPO, Aktis banked $346 million … than a dozen firms pricing IPOs, according to BioPharma Dive … Lilly, Bristol Myers Squibb. and Novartis. The latter, in particular, …
-
RNA specialist Ribo files $205m IPO in Hong Kong
06 Jan 2026 16:28 GMT
… has filed a Hong Kong IPO, aiming to raise new funds … thrombotic diseases.
Ribo's IPO is aiming to raise around … ; Johnson (milvexian), and antibodies from Novartis (abelacimab) and MSD/Adimab …
-
Radiopharmaceutical specialist Aktis seeks an IPO
22 Dec 2025 15:18 GMT
… company to file for an initial public offering in several weeks, outlining … them Merck & Co., Novartis and Bristol Myers Squibb. It … private financing before submitting its IPO paperwork.
Dive Insight:
… to forget for biotech IPOs.
Already in the throes …
-
Radiopharma-Focused Aktis Squeezes in IPO to End Biotech Drought
22 Dec 2025 16:25 GMT
… squeezing in a last-minute IPO to end the year, snapping … . In addition to Lilly, Sanofi, Novartis, AstraZeneca and Bristol Myers Squibb … major plays in the space. Novartis is the noted leader, with …
-
Medline’s Blockbuster IPO–And Its Billionaire Founding Family
10 Dec 2025 18:09 GMT
… of InnovationRx, Medline’s blockbuster IPO, Fred Moll’s surgical robotics …
Medical supplies giant Medline’s IPO is set to be this … . biotech Relation will work with Novartis to find allergic disease drug …
-
BSEC assures fair pricing under new IPO rules
08 Dec 2025 20:42 GMT
… capital market under the revised Initial Public Offering (IPO) rules will receive fair pricing … companies to review the draft IPO rules and discuss mechanisms … Corporation, Synovia Pharma PLC, Novartis Bangladesh, Karnaphuli Gas Distribution Company …
-
Rx Rundown: Nvidia, Johnson & Johnson, AbbVie and more
16 Jan 2026 12:57 GMT
… prices and gain tariff exemptions.
Novartis is spending $165 million upfront … million in its initial public offering.
Eikon Therapeutics filed for its IPO.
Orca Bio … data appears competitive with Novartis and Terns Pharma.
Novartis announced plans to …
-
Evommune nabs $150M in IPO amid federal shutdown
06 Nov 2025 05:41 GMT
… , priced a $150 million initial public offering on Wednesday.
The Palo Alto … a newly approved therapy from Novartis, is associated with certain side … , afterwards.
Prior to its IPO, Evommune had raised $267 … two dozen that had priced IPOs by this time last …